Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Therapeutic Solutions International Inc (TSOI)

Therapeutic Solutions International Inc (TSOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TSOI with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0006 +16.67%
on 04/09/24
0.0011 -36.36%
on 04/02/24
-0.0002 (-22.22%)
since 03/18/24
3-Month
0.0006 +16.67%
on 04/09/24
0.0016 -56.25%
on 01/24/24
-0.0007 (-50.00%)
since 01/18/24
52-Week
0.0006 +16.67%
on 04/09/24
0.0063 -88.89%
on 04/20/23
-0.0017 (-70.83%)
since 04/18/23

Most Recent Stories

More News
Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy

Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the “living timebomb” condition of aortic aneurysms using stem cell...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy

Therapeutic Solutions International (TSOI) announced today filing of a new Phase III clinical trial application with the FDA for use of its JadiCell adult stem cells in treatment of acute respiratory distress...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Spin Off Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia

Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced new data, covered by its previously filed patents, demonstrating that CampbellCell universal donor stem cells...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.

Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced today the appointment of Thomas Ichim, Ph.D., as President, and Chief Executive Officer of Campbell Neurosciences....

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations

Therapeutic Solutions International (TSOI) announced today its Spin Off Company, Campbell Neurosciences, Inc., obtained successful validation of its suicidal ideation predictive test using a saliva based...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Advances Chronic Obstructive Pulmonary Disease Program by Identifying Novel B Regulatory Cell Mechanism of Action for JadiCell Universal Donor Adult Stem Cell

Therapeutic Solutions International (TSOI) announced today new data and filing of a patent covering the discovery that JadiCell therapeutic activity in a model of Chronic Obstructive Pulmonary Disease...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Announces Plans to Initiate Breast Cancer Clinical Trial Using FloraStilbene™ Immune Stimulator Through Res Nova Bio Subsidiary

Therapeutic Solutions International (TSOI) announced today plans to initiate ten patient proof-of-concept clinical trial aimed at demonstrating the ability of FloraStilbene™ to stimulate the immune system...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics

Therapeutic Solutions International (TSOI) announced the launching of the Veltmeyer Institute for Advanced Biologics ( www.veltmeyerinstitute.org ). The organization is focused on providing patients access...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Res Nova Bio Leverages Immunological Similarities between Abortion Pill and Cancer Remission to Create Novel Immunotherapy

Therapeutic Solutions International (TSOI) announced today paradigm shifting findings leveraging the age-old immunological paradigm that cancer is an uncontrolled replica of pregnancy. Pregnancy has historically...

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)
Therapeutic Solutions International Spin Off Res Nova Bio Announces Recruitment of President and Chief Executive Officer

Therapeutic Solutions International (TSOI) announced today the recruitment of Ms. Famela Ramos as Chief Executive Officer of Res Nova Bio, Inc., as well as formation of an Advisory Board to guide the Company....

OTC.VN : 0.310 (-10.14%)
TSOI : 0.0007 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0009
2nd Resistance Point 0.0008
1st Resistance Point 0.0008
Last Price 0.0007
1st Support Level 0.0007
2nd Support Level 0.0006
3rd Support Level 0.0006

See More

52-Week High 0.0063
Fibonacci 61.8% 0.0041
Fibonacci 50% 0.0034
Fibonacci 38.2% 0.0028
Last Price 0.0007
52-Week Low 0.0006

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar